Persistent Fibrinolysis Shutdown Is Associated with Increased Mortality in Severely Injured Trauma Patients

Journal of the American College of Surgeons

Volumn 224, Issue 4, 2017, Pages 575-582

  Meizoso, Jonathan P ^a   Karcutskie, Charles A ^a   Ray, Juliet J ^a   Namias, Nicholas ^a   Schulman, Carl I ^a   Proctor, Kenneth G ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANEXAMIC ACID;

ADULT; BLOOD CLOT LYSIS; BLOOD TRANSFUSION; CONFERENCE PAPER; CRITICALLY ILL PATIENT; ERYTHROCYTE TRANSFUSION; FEMALE; GLASGOW COMA SCALE; HEAD INJURY; HEMATOLOGIC DISEASE; HOSPITAL ADMISSION; HUMAN; INJURY SCALE; INJURY SEVERITY; INTENSIVE CARE UNIT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; OBSERVATIONAL STUDY; PENETRATING TRAUMA; PERSISTENT FIBRINOLYSIS SHUTDOWN; PRIORITY JOURNAL; PROSPECTIVE STUDY; THROMBOCYTE TRANSFUSION; THROMBOELASTOGRAPHY; BLOOD COAGULATION DISORDERS; CRITICAL ILLNESS; FIBRINOLYSIS; HOSPITAL MORTALITY; INCIDENCE; MIDDLE AGED; PATHOPHYSIOLOGY; PROGNOSIS; RISK FACTOR; STATISTICAL MODEL; WOUNDS AND INJURIES;

ADULT; BLOOD COAGULATION DISORDERS; CRITICAL ILLNESS; FEMALE; FIBRINOLYSIS; HOSPITAL MORTALITY; HUMANS; INCIDENCE; INJURY SEVERITY SCORE; LOGISTIC MODELS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; THROMBELASTOGRAPHY; WOUNDS AND INJURIES;

EID: 85012891144     PISSN: 10727515     EISSN: 18791190     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2016.12.018     Document Type: Conference Paper

References (31)

1. 1 Innes, D., Sevitt, S., Coagulation and fibrinolysis in injured patients. J Clin Pathol 17 (1964), 1–13.
2. 2 Borowiecki, B., Sharp, A.A., Trauma and fibrinolysis. J Trauma 9 (1969), 522–536.
3. 3 Enderson, B.L., Chen, J.P., Robinson, R., Maull, K.I., Fibrinolysis in multisystem trauma patients. J Trauma 31 (1991), 1240–1246.
4. 4 Moore, E.E., Moore, H.B., Gonzalez, E., et al. Rationale for the selective administration of tranexamic acid to inhibit fibrinolysis in the severely injured patient. Transfusion (Paris) 56:Suppl 2 (2016), S110–S114.
5. 5 Brohi, K., Singh, J., Heron, M., Coats, T., Acute traumatic coagulopathy. J Trauma 54 (2003), 1127–1130.
6. 6 MacLeod, J.B., Lynn, M., McKenney, M.G., et al. Early coagulopathy predicts mortality in trauma. J Trauma 55 (2003), 39–44.
7. 7 Schochl, H., Frietsch, T., Pavelka, M., Jambor, C., Hyperfibrinolysis after major trauma: differential diagnosis of lysis patterns and prognostic value of thrombelastometry. J Trauma 67 (2009), 125–131.
8. 8 Kashuk, J.L., Moore, E.E., Sawyer, M., et al. Primary fibrinolysis is integral in the pathogenesis of the acute coagulopathy of trauma. Ann Surg 252 (2010), 434–442 discussion 443–444.
9. 9 Cotton, B.A., Harvin, J.A., Kostousouv, V., et al. Hyperfibrinolysis at admission is an uncommon but highly lethal event associated with shock and prehospital fluid administration. J Trauma Acute Care Surg 73 (2012), 365–370 discussion 370.
10. 10 Ives, C., Inaba, K., Branco, B.C., et al. Hyperfibrinolysis elicited via thromboelastography predicts mortality in trauma. J Am Coll Surg 215 (2012), 496–502.
11. 11 Cardenas, J.C., Matijevic, N., Baer, L.A., et al. Elevated tissue plasminogen activator and reduced plasminogen activator inhibitor promote hyperfibrinolysis in trauma patients. Shock 41 (2014), 514–521.
12. 12 Moore, H.B., Moore, E.E., Gonzalez, E., et al. Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown: the spectrum of postinjury fibrinolysis and relevance to antifibrinolytic therapy. J Trauma Acute Care Surg 77 (2014), 811–817 discussion 817.
13. 13 Chapman, M.P., Moore, E.E., Moore, H.B., et al. Overwhelming tPA release, not PAI-1 degradation, is responsible for hyperfibrinolysis in severely injured trauma patients. J Trauma Acute Care Surg 80 (2016), 16–23 discussion 23–25.
14. 14 Moore, H.B., Moore, E.E., Lawson, P.J., et al. Fibrinolysis shutdown phenotype masks changes in rodent coagulation in tissue injury versus hemorrhagic shock. Surgery 158 (2015), 386–392.
15. 15 Moore, H.B., Moore, E.E., Liras, I.N., et al. Acute fibrinolysis shutdown after injury occurs frequently and increases mortality: a multicenter evaluation of 2,540 severely injured patients. J Am Coll Surg 222 (2016), 347–355.
16. 16 Schreiber, M.A., Differding, J., Thorborg, P., et al. Hypercoagulability is most prevalent early after injury and in female patients. J Trauma 58 (2005), 475–480 discussion 480–481.
17. 17 Van Haren, R.M., Thorson, C.M., Valle, E.J., et al. Hypercoagulability after burn injury. J Trauma Acute Care Surg 75 (2013), 37–43.
18. 18 Van Haren, R.M., Valle, E.J., Thorson, C.M., et al. Hypercoagulability and other risk factors in trauma intensive care unit patients with venous thromboembolism. J Trauma Acute Care Surg 76 (2014), 443–449.
19. 19 Chakrabarti, R., Hocking, E.D., Fearnley, G.R., Reaction pattern to three stresses–electroplexy, surgery, and myocardial infarction–of fibrinolysis and plasma fibrinogen. J Clin Pathol 22 (1969), 659–662.
20. 20 Greenfield, L.J., Proctor, M.C., Rodriguez, J.L., et al. Posttrauma thromboembolism prophylaxis. J Trauma 42 (1997), 100–103.
21. 21 Moore, H.B., Moore, E.E., Morton, A.P., et al. Shock-induced systemic hyperfibrinolysis is attenuated by plasma-first resuscitation. J Trauma Acute Care Surg 79 (2015), 897–903 discussion 903–904.
22. 22 Shakur, H., Roberts, I., Bautista, R., et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 376 (2010), 23–32.
23. 23 Valle, E.J., Allen, C.J., Van Haren, R.M., et al. Do all trauma patients benefit from tranexamic acid?. J Trauma Acute Care Surg 76 (2014), 1373–1378.
24. 24 Harvin, J.A., Peirce, C.A., Mims, M.M., et al. The impact of tranexamic acid on mortality in injured patients with hyperfibrinolysis. J Trauma Acute Care Surg 78 (2015), 905–909 discussion 909–911.
25. 25 Allen, C.J., Valle, E.J., Jouria, J.M., et al. Differences between blunt and penetrating trauma after resuscitation with hydroxyethyl starch. J Trauma Acute Care Surg 77 (2014), 859–864.
26. 26 Meizoso, J.P., Ray, J.J., Karcutskie, C.A., et al. Admission hyperglycemia is associated with different outcomes after blunt versus penetrating trauma. J Surg Res 206 (2016), 83–89.
27. 27 Holcomb, J.B., Fluid resuscitation in modern combat casualty care: lessons learned from Somalia. J Trauma 54:5 Suppl (2003), S46–S51.
28. 28 McSwain, N.E., Champion, H.R., Fabian, T.C., et al. State of the art of fluid resuscitation 2010: prehospital and immediate transition to the hospital. J Trauma 70:5 Suppl (2011), S2–S10.
29. 29 James, M.F., Michell, W.L., Joubert, I.A., et al. Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma). Br J Anaesth 107 (2011), 693–702.
30. 30 Karcutskie, C.A., Meizoso, J.P., Ray, J.J., et al. Association of mechanism of injury with risk for venous thromboembolism after trauma. JAMA Surg 152 (2017), 35–40.
31. 31 Chapman, M.P., Moore, E.E., Ramos, C.R., et al. Fibrinolysis greater than 3% is the critical value for initiation of antifibrinolytic therapy. J Trauma Acute Care Surg 75 (2013), 961–967 discussion 967.